Chugai Pharm Unsp/Adr (CHGCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 8,428,205 | 7,726,033 | 7,890,706 | 9,701,584 | 9,097,807 |
| Cost of Goods | 2,436,723 | 2,240,099 | 2,934,473 | 3,667,133 | 3,077,138 |
| Gross Profit | 5,991,482 | 5,485,927 | 4,956,233 | 6,034,452 | 6,020,669 |
| Operating Expenses | 1,980,023 | 1,908,813 | 1,838,570 | 1,928,105 | 2,181,544 |
| Operating Income | 4,012,181 | 3,577,213 | 3,118,135 | 4,106,479 | 3,839,263 |
| Interest Expense | 1,387 | 33 | 192 | 470 | 437 |
| Other Income | -5,487 | 6,844 | 33,186 | -16,031 | -22,422 |
| Pre-tax Income | 4,005,307 | 3,584,024 | 3,151,129 | 4,089,978 | 3,816,404 |
| Income Tax | 1,097,420 | 1,027,732 | 840,278 | 1,206,875 | 1,059,149 |
| Net Income Continuous | 2,907,880 | 2,556,292 | 2,310,851 | 2,883,104 | 2,757,254 |
| Net Income | $2,907,880 | $2,556,292 | $2,310,851 | $2,883,103 | $2,757,254 |
| EPS Basic Total Ops | 0.88 | 0.78 | 0.70 | 0.88 | 0.84 |
| EPS Basic Continuous Ops | 0.88 | 0.78 | 0.70 | 0.88 | 0.84 |
| EPS Diluted Total Ops | 0.88 | 0.78 | 0.70 | 0.88 | 0.84 |
| EPS Diluted Continuous Ops | 0.88 | 0.78 | 0.70 | 0.88 | 0.84 |
| EPS Diluted Before Non-Recurring Items | 0.88 | 0.78 | 0.71 | 0.87 | 0.84 |
| EBITDA(a) | $4,230,166 | $3,786,209 | $3,343,490 | $4,348,521 | $4,120,162 |